Abstract
We report a case of bilateral optic neuropathy associated with the CREST syndrome, a variant of scleroderma. Immunosuppressive therapy achieved significant improvement of the visual symptoms for two years. The pathophysiological mechanisms underlying this unique association remain unclear.
MeSH terms
-
Adult
-
Azathioprine / therapeutic use
-
CREST Syndrome / complications*
-
CREST Syndrome / drug therapy
-
Female
-
Fluorescein Angiography
-
Fundus Oculi
-
Humans
-
Methylprednisolone / therapeutic use
-
Optic Nerve Diseases / drug therapy
-
Optic Nerve Diseases / etiology*
-
Visual Acuity
-
Visual Fields
Substances
-
Azathioprine
-
Methylprednisolone